SEC Form 4 research
| Issuer | First Tracks Biotherapeutics, Inc. |
|---|---|
| Tickers | TRAX |
| Reporting owners | 12 |
| Officers and directors | 1 |
| Last public filing | 2026-09-05 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-09-04 | 2026-09-02 | Ware J. Anthony | S | 39,265 | $44.78 | Not reported |
| 2026-08-18 | 2026-08-15 | STONE BENJAMIN | A | 60,492 | $0 | Not reported |
| 2026-08-18 | 2026-08-15 | Lizzul Paul F. | A | 60,492 | $0 | Not reported |
| 2026-08-18 | 2026-08-15 | Faga Daniel | A | 193,575 | $0 | Not reported |
| 2026-08-05 | 2026-08-02 | STONE BENJAMIN | A | 60,492 | $0 | Not reported |
| 2026-08-05 | 2026-08-02 | Lizzul Paul F. | A | 60,492 | $0 | Not reported |
| 2026-08-05 | 2026-08-02 | Faga Daniel | A | 193,576 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.